Eye Care Netherlands

We are sorry but this premium report expired!

This market research, not available anymore on the publisher's website, was withdrawn from our database.

To get an alternative report, you can either :

  • Have a look at the list of documents hereafter
  • Launch a new search below

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

DOWNLOAD THESE REPORTS NOW!

Genmed Holding Corp. (Symbol:GENM) SWOT Analysis, Strategy, Revenues and Profits

Genmed Holding Corp. (Symbol:GENM) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • by Global Data
  • October 2014
  • 25 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. Genmed Holding Corp. SWOT Analysis report provides you a strategic ...

Industries: Drug and Medication | Countries: Netherlands, Luxembourg, Ireland, France, Germany, Belgium

NRT Smoking Cessation Aids Market Analysis in the Netherlands

NRT Smoking Cessation Aids Market Analysis in the Netherlands

  • $ 898
  • Industry report
  • by Euromonitor International
  • September 2014
  • 24 pages

Sales of NRT smoking cessation aids registered healthy current value growth of 5% in the Netherlands but lower than expected considering the higher restrictions on smoking in public places and the general health trend among the population. Sales recorded sustained growth when compared with the previous ...

Industries: Drug and Medication, Tobacco | Countries: Netherlands

Analgesics Market Analysis in the Netherlands

Analgesics Market Analysis in the Netherlands

  • $ 898
  • Industry report
  • by Euromonitor International
  • September 2014
  • 27 pages

Current value sales of analgesics were positive in 2011 but marginally lower than 2010. Analgesics sales were impacted by changes in distribution legislation introduced during the second half of 2010 which involved placing restrictions on the sale of large content packs for these products via paraph ...

Industries: Drug and Medication | Countries: Netherlands

Cough, Cold and Allergy (Hay Fever) Remedies Market Analysis in the Netherlands

Cough, Cold and Allergy (Hay Fever) Remedies Market Analysis in the Netherlands

  • $ 898
  • Industry report
  • by Euromonitor International
  • September 2014
  • 29 pages

Cough, cold and allergy (hay fever) remedies emerged as one of the most dynamic categories within consumer health in the Netherland in 2011 as was the case in 2010. Manufacturers poured resources into promoting more advanced formulas. Euromonitor International's Cough, Cold and Allergy (Hay Fever) Remedies ...

Industries: Drug and Medication | Countries: Netherlands

Netherlands Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

Netherlands Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

  • $ 1 300
  • Industry report
  • by Business Monitor International
  • August 2014
  • 120 pages

BMI View: The Netherlands has a well established pharmaceutical market with strength in vaccines and biologics. As a result, the country has the necessary infrastructure and skilled workforce to be regarded as a base for innovative drugmakers. Although the domestic pricing and reimbursement situation ...

Industries: Drug and Medication | Countries: Netherlands

Netherlands Pharmaceuticals and Healthcare Industry Update Quarter 3 2012

Netherlands Pharmaceuticals and Healthcare Industry Update Quarter 3 2012

  • $ 1 300
  • Industry report
  • by Business Monitor International
  • May 2014
  • 115 pages

Includes 3 FREE quarterly updates BMI View: While the Netherlands is a low risk industry from the point of view of multinational drugmakers, the country’s modest per capita expenditure on pharmaceuticals relative to other Western Europe countries remains an issue. A further challenge facing drugmakers ...

Industries: Drug and Medication | Countries: Netherlands

Netherlands Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

Netherlands Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

  • $ 1 300
  • Industry report
  • by Business Monitor International
  • February 2014
  • 120 pages

BMI View: While the Netherlands is a low risk industry from the point of view of multinational drugmakers, the country’s modest per capita expenditure on pharmaceuticals relative to other Western Europe countries remains an issue. A further challenge facing drugmakers is cost-containment, which can ...

Industries: Drug and Medication | Countries: Netherlands

Netherlands Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

Netherlands Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

  • $ 1 300
  • Industry report
  • by Business Monitor International
  • November 2013
  • 115 pages

BMI View: The Netherlands boasts a well-developed healthcare system and also an advanced pharmaceutical market, which has attracted significant domestic and foreign investment over the years. Demographic and epidemiological needs of the country have similarly stimulated the use of patented drugs. However, ...

Industries: Drug and Medication | Countries: Netherlands

Ear Care in the Netherlands

Ear Care in the Netherlands

  • $ 898
  • Industry report
  • by Euromonitor International
  • September 2013
  • 23 pages

Sales of ear care registered marginally improved current value growth of 6% in 2012 compared to 5% growth in the previous year. Increased demand for ear care is attributed to promotional efforts from main manufacturers aimed at making consumers aware of the benefits of maintaining good ear health. Euromonito ...

Industries: Drug and Medication | Countries: Netherlands

Emergency Contraception in the Netherlands

Emergency Contraception in the Netherlands

  • $ 898
  • Industry report
  • by Euromonitor International
  • September 2013
  • 23 pages

OTC emergency contraception began when these products were switched from prescription only to OTC in late 2004. Despite initially more optimistic prospects, sales have remained relatively low in the Netherlands, perhaps explained by the relatively low level of unwanted pregnancies amongst the young population. ...

Industries: Drug and Medication | Countries: Netherlands

24/7 Customer Service

You can call our customer service 24 hours a day / 7 days a week

  • +1 718 303 2019

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.